Geode Capital Management’s Quince Therapeutics QNCX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $655K | Buy |
396,982
+1,272
| +0.3% | +$2.1K | ﹤0.01% | 3469 |
|
2025
Q1 | $526K | Buy |
395,710
+19,778
| +5% | +$26.3K | ﹤0.01% | 3522 |
|
2024
Q4 | $703K | Buy |
375,932
+36,807
| +11% | +$68.8K | ﹤0.01% | 3491 |
|
2024
Q3 | $263K | Buy |
339,125
+66,170
| +24% | +$51.4K | ﹤0.01% | 3815 |
|
2024
Q2 | $205K | Buy |
272,955
+6,059
| +2% | +$4.55K | ﹤0.01% | 3900 |
|
2024
Q1 | $283K | Buy |
266,896
+5,158
| +2% | +$5.47K | ﹤0.01% | 3817 |
|
2023
Q4 | $275K | Buy |
261,738
+42,135
| +19% | +$44.3K | ﹤0.01% | 3836 |
|
2023
Q3 | $246K | Buy |
219,603
+32,441
| +17% | +$36.3K | ﹤0.01% | 3900 |
|
2023
Q2 | $282K | Buy |
187,162
+50,076
| +37% | +$75.4K | ﹤0.01% | 3893 |
|
2023
Q1 | $214K | Hold |
137,086
| – | – | ﹤0.01% | 4015 |
|
2022
Q4 | $87K | Sell |
137,086
-9,128
| -6% | -$5.79K | ﹤0.01% | 4444 |
|
2022
Q3 | $194K | Hold |
146,214
| – | – | ﹤0.01% | 4229 |
|
2022
Q2 | $324K | Sell |
146,214
-136,897
| -48% | -$303K | ﹤0.01% | 3992 |
|
2022
Q1 | $1.75M | Sell |
283,111
-26,490
| -9% | -$164K | ﹤0.01% | 3320 |
|
2021
Q4 | $3.91M | Sell |
309,601
-20,246
| -6% | -$255K | ﹤0.01% | 3027 |
|
2021
Q3 | $30.2M | Buy |
329,847
+28,135
| +9% | +$2.58M | ﹤0.01% | 1691 |
|
2021
Q2 | $16M | Buy |
301,712
+42,405
| +16% | +$2.25M | ﹤0.01% | 2122 |
|
2021
Q1 | $9.34M | Buy |
259,307
+23,359
| +10% | +$842K | ﹤0.01% | 2409 |
|
2020
Q4 | $6.55M | Sell |
235,948
-5,302
| -2% | -$147K | ﹤0.01% | 2442 |
|
2020
Q3 | $12.1M | Buy |
241,250
+71,124
| +42% | +$3.56M | ﹤0.01% | 1843 |
|
2020
Q2 | $7.88M | Buy |
170,126
+35,747
| +27% | +$1.65M | ﹤0.01% | 2075 |
|
2020
Q1 | $6.13M | Buy |
134,379
+27,538
| +26% | +$1.26M | ﹤0.01% | 2021 |
|
2019
Q4 | $6M | Buy |
106,841
+50,336
| +89% | +$2.83M | ﹤0.01% | 2337 |
|
2019
Q3 | $1.41M | Buy |
56,505
+2,529
| +5% | +$63K | ﹤0.01% | 3106 |
|
2019
Q2 | $2.29M | Buy |
+53,976
| New | +$2.29M | ﹤0.01% | 2858 |
|